- Home
- ACON vs SXTP Comparison
ACON vs SXTP Comparison
Compare ACON & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- SXTP
- Stock Information
- Founded
- ACON 2008
- SXTP 2010
- Country
- ACON United States
- SXTP United States
- Employees
- ACON N/A
- SXTP N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- SXTP Health Care
- Exchange
- ACON Nasdaq
- SXTP Nasdaq
- Market Cap
- ACON 1.7M
- SXTP 1.6M
- IPO Year
- ACON 2022
- SXTP 2023
- Fundamental
- Price
- ACON $0.11
- SXTP $1.38
- Analyst Decision
- ACON Buy
- SXTP Hold
- Analyst Count
- ACON 2
- SXTP 1
- Target Price
- ACON $1.30
- SXTP N/A
- AVG Volume (30 Days)
- ACON 991.9K
- SXTP 712.1K
- Earning Date
- ACON 11-14-2024
- SXTP 11-14-2024
- Dividend Yield
- ACON N/A
- SXTP N/A
- EPS Growth
- ACON N/A
- SXTP N/A
- EPS
- ACON N/A
- SXTP N/A
- Revenue
- ACON $49,289.00
- SXTP $462,612.00
- Revenue This Year
- ACON N/A
- SXTP $267.05
- Revenue Next Year
- ACON $186.36
- SXTP $181.82
- P/E Ratio
- ACON N/A
- SXTP N/A
- Revenue Growth
- ACON N/A
- SXTP 128.99
- 52 Week Low
- ACON $0.10
- SXTP $0.70
- 52 Week High
- ACON $7.39
- SXTP $18.36
- Technical
- Relative Strength Index (RSI)
- ACON 30.75
- SXTP 52.58
- Support Level
- ACON $0.16
- SXTP $1.35
- Resistance Level
- ACON $0.20
- SXTP $1.74
- Average True Range (ATR)
- ACON 0.02
- SXTP 0.28
- MACD
- ACON -0.01
- SXTP 0.01
- Stochastic Oscillator
- ACON 13.37
- SXTP 26.00
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.